Page last updated: 2024-11-04

suramin and Urogenital Neoplasms

suramin has been researched along with Urogenital Neoplasms in 2 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Urogenital Neoplasms: Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheson, BD1
Phillips, PH1
Pluda, JM1
Christian, M1
Scher, HI1
Heston, WD1

Reviews

1 review available for suramin and Urogenital Neoplasms

ArticleYear
Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumors.
    Cancer treatment and research, 1992, Volume: 59

    Topics: Growth Inhibitors; Humans; Male; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured; Urogenital Neo

1992

Other Studies

1 other study available for suramin and Urogenital Neoplasms

ArticleYear
Clinical trials referral resource. Clinical trials of suramin.
    Oncology (Williston Park, N.Y.), 1995, Volume: 9, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Humans; Leukemia; Lymphoma; Suram

1995